Professional Documents
Culture Documents
NeuroImage
j o u r n a l h o m e p a g e : w w w. e l s e v i e r. c o m / l o c a t e / y n i m g
a r t i c l e
i n f o
Article history:
Received 18 September 2009
Revised 24 November 2009
Accepted 26 November 2009
Available online 5 December 2009
Keywords:
Serotonin transporter
Amygdala
Volition
Cognitive emotion regulation
fMRI
a b s t r a c t
Individuals carrying the short allele of a common polymorphism in the promoter region of the serotonin
transporter gene (5-HTTLPR) exhibit heightened amygdala responses to passive stimulation with aversive
emotional material. In turn, the level of amygdala activation in response to emotion can be decreased by
will, for example by using cognitive emotion regulation strategies. In the present study, 37 female subjects
(s-carriers: n = 21; l/l-homozygotes: n = 16) performed an emotion regulation task during functional
magnetic resonance imaging to determine whether cognitive emotion regulation can modulate the
genetically determined amygdala hyperreactivity in 5-HTTLPR short allele carriers. Our results demonstrate
that cognitive emotion regulation diminishes the difference in amygdala reactivity to threat-related stimuli
between 5-HTTLPR genotype groups. Furthermore, we also provide evidence that the effect of cognitive
regulation is mediated through altered coupling between the amygdala and prefrontal regulatory regions.
Our ndings demonstrate that while the presence of the 5-HTTLPR short allele leads to heightened
responses in the amygdala, cognitive regulation can modify genetically mediated effects upon brain function
by volitionally altering prefrontal-amygdala connectivity.
2009 Elsevier Inc. All rights reserved.
Introduction
Recent advances in imaging genetics have provided promising new
insights into the complex interplay of genes, neural processing and
behavior (Esslinger et al., 2009; Green et al., 2008; Meyer-Lindenberg
and Weinberger, 2006). For example, the neurotransmitter serotonin
(5-hydroxytryptamine, 5-HT) is critically involved in emotional
processing, stimulating imaging genetic studies of this neuromodulatory system (Hahn and Blakely, 2007). One well-described determinant of this system is the serotonin transporter (5-HTT), which
regulates 5-HT reuptake from the synaptic cleft (Hariri and Holmes,
2006). On the molecular level, genetic regulation of 5-HTT mRNA and
protein expression is inuenced by a common polymorphism found in
the 5-HTT linked promoter region (5-HTTLPR) of the serotonin
transporter gene SLC6A4. In the presence of at least one short (s)
allele, the level of 5-HTT mRNA and 5-HT reuptake in human
lymphoblastoid cells is approximately two-fold lower compared
with cells that are homozygous for the long (l) allele.
944
Heinz et al., 2005; Pezawas et al., 2005). The observed genotypedependent dysregulations regarding the structure, function and
connectivity within the amygdala-prefrontal emotion network are
thought to contribute to the increased negative emotionality observed
in s-allele carriers (Canli and Lesch, 2007; Hariri and Holmes, 2006).
These ndings clearly underscore the relevance of genetic variation
within the serotonergic system with respect to the central processing
of emotions, despite heterogeneous results regarding the inuence of
the 5-HTTLPR genotype on direct measures of 5-HTT central
availability. While some studies found that 5-HTT central availability
and mRNA levels in midbrain regions are inuenced by the serotonin
transporter genotype (Little et al., 1998; Reimold et al., 2007; van Dyck
et al., 2004), others failed to nd an association (Parsey et al., 2006;
Shioe et al., 2003). For example, a PET investigation with the
radiotracer [11C]McN 5652 found no effect of 5-HTTLPR genotypes
on serotonin transporter binding potential in the amygdala (Parsey
et al., 2006). This led the authors to conclude that 5-HTTLPR related
neural effects cannot be explained by altered serotonin transporter
binding but may be due to differences in methylation patterns or
changes in maximum velocity in the 5-HTT enzymatic reaction. Since
the association between the 5-HTTLPR and central measures of
emotional reactivity has however been reliably replicated, it also
seems reasonable to assume that a relative loss in serotonin
transporter function related to the short variant might have a
detrimental effect especially during the development of the neural
circuits involved in emotional regulation (Hariri and Holmes, 2006;
Parsey et al., 2006). Consistent with this notion, in rodents a disruption
in 5-HT functioning during early development entails alterations in
neural structure and function, such as for example lasting emotional
abnormalities (Esaki et al., 2005; Gaspar et al., 2003).
However, all previous investigations of 5-HTTLPR-dependent
effects on the neural processing of emotions have been restricted to
passive perception. In turn, the willful employment of cognitive
strategies is known to be effective in changing subjective and
physiological responses to emotional stimuli. Amygdala activation is
effectively reduced during e.g. labeling (Hariri et al., 2003), cognitive
reappraisal (Goldin et al., 2008; Ochsner et al., 2002, 2004) and
detachment (Beauregard et al., 2001; Levesque et al., 2004) through
topdown inuences from the dlPFC and vlPFC, the orbitofrontal
cortex (OFC) and the parietal cortex. Thus, the question arises if willful
emotion regulation is able to alter genetically determined differences
in amygdala reactivity. This question is not only relevant within
cognitive and clinical neuroscience but also touches questions related
to the power of conscious will. Recent years have witnessed a number
of studies trying to answer questions related to the power of
conscious will not by armchair philosophy but by conducting
empirical studies of the will using neuroscientic means (Bechara,
2005; Haggard, 2008; Soon et al., 2008; Walter, 2001; Wegner, 2004).
To investigate the effect that willful cognitive acts have on
genetically predisposed emotional processing, we conducted a functional magnetic resonance imaging (fMRI) study investigating the
passive perception and explicit regulation of negative and neutral
emotional material in female 5-HTTLPR short and long individuals.
Since on the one hand the s-allele of the serotonin transporter genotype
has been associated with amygdala hyperreactivity (Hariri et al., 2002,
2005), and on the other hand, amygdala BOLD signal is effectively
attenuated through cognitive emotion regulation (Beauregard et al.,
2001; Goldin et al., 2008; Levesque et al., 2004; Ochsner et al., 2002,
2004), this region was designated our a priori region of interest.
Our primary goal was to evaluate whether a willful effort, i.e. the
deliberate use of a cognitive emotion regulation strategy, can reduce
the genetically mediated amygdala hyperreactivity to aversive
emotional material. We used negative stimuli that evoked either
fear or disgust in order to evaluate whether s-allele carriers show
increased neural activation to the perception of aversive versus
neutral stimuli (Calder et al., 2001; Hariri et al., 2002). Since fear
945
Imaging
Data analysis
Functional task
The task completed by the participants during the scanning
session involved the natural experience of (perception) or active
detachment from (regulation) emotional responses following the
presentation of emotional stimuli in an event-related design successfully used in prior studies (Staudinger et al., 2009; Walter et al., 2009).
Participants viewed fear, disgust and neutral pictures from a
standardized stimulus set (Lang et al., 2008), matched for complexity,
content, color and brightness. Some additional pictures in the disgust
condition were collected by the authors to balance picture content
across conditions. During the perception condition, participants were
instructed to look at the picture and permit yourself to feel
whichever emotional response arises naturally, without trying to
alter it; in the regulation condition, they were to look at the picture
while detaching yourself from any emotional response which may
arise by adopting the position of a detached observer, who is not
affected by the scene presented in the picture. Participants were
trained outside the scanner until they felt condent to perform the
task during fMRI.
Thirty-two pictures of each valence were presented. Half of the
trials of each valence were presented with the perception instruction
and the other half with the regulation instruction. Subjects completed
four sessions of 24 trials each: two sessions included unregulated and
regulated fear and neutral trials; the other two sessions included
unregulated and regulated disgust and neutral trials. The sessions
containing fear and disgust were presented in alternating order; and
the order of sessions was counterbalanced across subjects (i.e. half of
the subjects started with a fear session, the other half started with a
disgust session). Within each session, trial presentation was pseudorandomized, with no more than two consecutive trials of the same
condition. A given trial began with an instruction of 2 s, followed by
8 s of picture presentation, and ended with a xation of 12 s during
which participants were instructed to relax.
After the scanning session, participants lled in a questionnaire
containing all 96 previously presented pictures. They rated the overall
valence of each picture (1very unpleasant to 9very pleasant) to
test whether aversive pictures were perceived as more negative than
neutral pictures. Additional ratings were obtained assessing the
overall compliance with the instructed detachment strategy (1
never used it to 9always used it) and the success at implementing
the strategy (1not at all successful to 9very successful). To
ensure that equal attention was paid to both regulated and
unregulated pictures, subjects also indicated which strategy they
remember to have followed during each picture's presentation.
Behavioral data
For the pleasantness and memory ratings, repeated-measures
ANOVAs were carried out to asses the effects of genotype (s-group,
l-group), regulation (perception [p], regulation [r]) and valence (fear
[F], disgust [D], neutral [X]). Regarding the compliance and regulation
success ratings, the effect of the 5-HTTLRP genotype was assessed
by independent-samples t-tests comparing the scores between the
s-group and the l-group. Statistical analyses of the behavioral data
were thresholded at p b 0.05. A GreenhouseGeisser correction was
applied where appropriate in the case of non-sphericity.
946
Personality scores
The 5-HTTLPR genotype groups did not differ regarding harm
avoidance or neuroticism scores (HA: t[35] = 1.55, p = 0.13; N:
t[35] = 1.66, p = 0.11). The habitual use of suppression was also
unaffected by 5-HTTLPR genotype (ERQ-S: t[35] = 0.63, p = 0.53).
However, the habitual use of reappraisal was more frequent in l/lhomozygotes compared with 5-HTTLPR s-allele carriers (t[35] =
2.42, p = 0.02).
Manipulation check
Both fear and disgust stimuli were perceived as signicantly more
unpleasant in comparison with the neutral stimuli (valence: F[2,70]
= 402.58, p b 0.0001). Subjects attended the regulated stimuli well:
when asked to indicate the condition under which a picture had been
presented during fMRI, hit rates were higher for the two negative
conditions (valence: F[2,70] = 5.1, p b 0.01) and especially so for the
regulated stimuli (valence regulation: F[2,70] = 57.6, p b 0.0001).
The 5-HTTLPR genotype did not have any effects on pleasantness
ratings or hit rates (all p N 0.12).
The compliance with and success at implementing emotion
regulation was generally very high and did not differ between
Results
Behavioral results
947
Table 1
Overall effects of stimulus valence and regulation (s-allele carriers + l/l-homozygotes).
Regions
Right/left
Thalamus
Middle temporal/fusiform gyrus
L
R
R
L
R
L
L
R
R
L
R
L
L
L
R
L
R
Brodmann
area
37
36
39
40
9
47
6
35
40
19
19/37
11
13
18
18
Cluster size
(voxels)
t-score local
maximum
p-value
(FWE)
MNI coordinates
x
1
699
3
312
10
3.96
3.78
4.84
6.76
5.08
6.08
5.06
0.001
0.003
0.049
b 0.001
0.019
b 0.001
0.021
26
28
10
52
40
50
60
8
6
10
66
36
60
28
18
20
0
8
20
8
34
16
51
36
8
11
91
79
3336
24
3.94
5.47
5.29
5.66
5.74
5.04
5.19
5.46
5.35
9.21
5.40
0.002
b 0.001
0.008
0.002
0.001
0.023
0.012
0.004
0.006
b 0.001
0.005
22
22
50
32
10
16
62
26
36
42
8
2
2
6
30
6
28
30
78
78
64
24
18
16
30
10
68
4
40
26
18
6
12
3.49
3.54
4.98
5.33
4.44
7.96
7.62
7.12
6.39
6.15
5.4
0.007
0.006
0.029
0.007
b 0.001
b 0.001
b 0.001
b 0.001
b 0.001
0.005
28
16
2
2
32
26
24
6
12
8
24
0
8
6
54
14
92
92
44
48
40
28
18
14
6
12
22
2
4
0
6
0
6
8.55
8.29
7.31
5.15
7.28
5.42
6.5
9.17
5.53
4.88
5.53
b 0.001
b 0.001
b 0.001
0.014
b 0.001
b 0.004
b 0.001
b 0.001
0.003
0.043
0.003
34
38
32
4
24
44
40
56
56
16
36
40
48
46
28
6
14
16
52
52
60
50
32
4
8
40
68
44
4
40
44
62
46
2
24
85
1743
1109
1932
34
15
8/9
10
8
6
8
13/44
40
7
2075
496
12
387
33
289
1719
52
2
47
All coordinates are given in MNI space together with their t-scores. ROI: bilateral amygdala (x, y, z = 26, 4, 16), signicance threshold for ROI analyses p b 0.05 FWE-corrected
for small volume. Whole-brain analyses were thresholded at p b 0.05 FWE-corrected for multiple comparisons. pF: perception fear; pD: perception disgust; pX: perception neutral;
rF: regulation fear; rD: regulation disgust; rX: regulation neutral.
948
Fig. 1. Increased amygdala signal attenuation during cognitive emotion regulation in 5-HTTLPR short allele carriers. (A) Individuals with the 5-HTTLPR short genotype exhibit greater
(p b .05 FWE-corrected for multiple comparisons) signal reduction in the right amygdala during the regulation of fear compared with l/l-homozygotes. (B) BOLD signal change values
(mean SEM) from the right amygdala ROI show that genotype-dependent group differences were driven by markedly increased activations during the perception but not the
regulation of fear in the s-group, while no such effect was observed for disgust or neutral stimuli. SEM: standard error of mean; pF: perception fear; pD: perception disgust; pX:
perception neutral; rF: regulation fear; rF: regulation disgust; rX: regulation neutral.
Fig. 2. Increased amygdala connectivity during cognitive emotion regulation in 5-HTTLPR short allele carriers. Increased functional coupling during the cognitive regulation of fear
(rF N pF) was observed in 5-HTTLPR s-allele carriers between the right amygdala seed region around x, y, z = 26, 4, 16, and the bilateral ventrolateral prefrontal cortex, left
medial orbitofrontal cortex, right premotor cortex as well as rostral and subgenual parts of the anterior cingulate cortex. The threshold for visualization is set to p b 0.005 uncorrected.
949
Table 2
Regions showing greater amygdala connectivity during fear regulation (rF-pF) in 5-HTTLPR short allele carriers.
Regions
Precuneus/cuneus
Right/left
Brodmann
area
Cluster size
(voxels)
t-score local
maximum
p-value
(uncorrected)
MNI coordinates
x
3.79
3.12
3.93
3.32
3.53
2.99
2.98
3.2
3.69
3.2
3.98
3.09
3.59
3.73
3.22
4.35
4.21
3.6
3.17
4.22
3.17
b0.001
0.002
b0.001
0.001
0.001
0.003
0.003
0.001
b0.001
0.001
b0.001
0.002
b0.001
b0.001
0.001
b0.001
b0.001
b0.001
0.002
b0.001
0.002
40
54
34
28
32
10
18
10
8
6
14
10
8
2
40
40
40
14
18
14
0
42
34
48
28
14
36
36
32
24
46
2
10
42
2
8
12
26
60
68
58
74
10
6
6
4
56
16
14
36
14
2
36
30
12
4
10
20
24
34
12
36
34
L
L
R
R
R
L
11
47
10
47
6
11
88
18
268
25
147
45
L
R
R
L
L
L
L
L
R
R
L
L
R
R
8
25
32
24
24
29
31
37
23
33
13
13
13
7/31
30
7
7
76
80
10
205
129
31
719
All coordinates are given in MNI space together with their t-scores. Whole-brain analyses were thresholded at b0.005 (uncorrected), 0.05 FWE-corrected for small volume.
life events (Munafo et al., 2008; Risch et al., 2009). However, while it
is well acknowledged that large and homogeneously assessed
samples are necessary to identify gene-environment interactions
(Hoefgen et al., 2005), the samples included in the above mentioned
meta-analyses are heterogeneous with respect to ethnicity, study
design, sample recruitment and assessment of stressful life events.
Moreover, the sample size of 1769 clinically depressed individuals
may still be too low to identify inuences of the serotonin transporter
genotype on a specic subgroup. Since depression is both clinically
and genetically heterogeneous, and the impact of stressful life events
on an individual at a given point in time is hard to determine, a
replication within the same study design is needed to reliably provide
or refute an association between the serotonin transporter genotype,
environmental factors and depression.
In the present design, however, we did not test the direct inuence
of the serotonin transporter genotype on depression per se; rather, we
examined quantitative measures of phenotypes of the cognitive
control of emotions which may underlie the etiology of depression.
The relevance of successful emotion regulation with regard to mood
disorders is underscored by reports of impaired cognitive emotion
regulation in clinically manifest depression. Whereas greater activation in the ventrolateral and ventromedial PFC was associated with
reduced amygdala activation in healthy controls, clinically depressed
individuals showed the reverse pattern, where greater reappraisal
effort was related to increased amygdala activation (Johnstone et al.,
2007). In our study, individuals with the risk genotype were able to
effectively attenuate amygdala hyperreactivity to fear-related stimuli
by means of cognitive regulation. This suggests that explicit strategies
may be benecial in attenuating genotype-dependent amygdala
activation, despite a less efcient automatic emotion regulation. In
fact, the efcacy of cognitive behavioral therapy for depressed or
depression-prone subjects might also rely on this mechanism
(Johnstone et al., 2007). Future investigations of 5-HTTLPR effects
on neural processing are needed to determine how explicit cognitive
as compared to automatic mechanisms of emotion regulation are
altered in depressed patients and whether explicit training in emotion
regulation strategies alters these effects.
Furthermore, the present sample comprised only female participants, while gender differences have been observed with respect to
the behavioral effects of the serotonin transporter genotype and
during cognitive emotion regulation. For example, in women, the 5HTTLPR short genotype led to a more cautious response style and more
negative mood during acute tryptophan depletion compared with
men (Walderhaug et al., 2007). In a Japanese sample, the effects of the
5-HTTLPR genotype on anxiety scores were also mediated by gender:
female ls heterozygous individuals showed greater anxiety scores than
ss or ll homozygous individuals, while in the male subgroup, the ss
homozygous individuals showed the highest anxiety scores (Mizuno
et al., 2006). McRae and colleagues (2008) reported that although
women did not differ from men with respect to the behavioral
outcomes of reappraisal, cognitive emotion regulation was associated
with greater prefrontal activation and lesser down-regulation in the
amygdala in women. The interpretation offered by the authors posits
that in men, cognitive emotion regulation may be associated with less
effort, possibly due to a greater use of automatic emotion regulation; a
conclusion which ts in well with the fact that the prevalence of
affective disorders is higher in women (Gater et al., 1998; Kessler et al.,
1993; Maciejewski et al., 2001; Wilhelm et al., 1997). Conversely,
previous studies of 5-HTTLPR-mediated amygdala activation to
negative emotional cues have not found evidence for gender-related
differences (Hariri et al., 2002, 2005), suggesting that higher amygdala
activation in short allele carriers is independent of gender. Moreover,
cognitive regulation led to decreased amygdala activation across both
genotype groups in our study, suggesting that the intended strategy is
effective in female subjects in general. Since our participants were not
recruited at a specic time during their menstrual cycle, while some
studies have found differences in emotional processing related to
hormonal changes (Amin et al., 2006; Goldstein et al., 2005; Pearson
and Lewis, 2005; Protopopescu et al., 2005), we cannot exclude that
our ndings are biased in this respect. However, the genotypedependent modulation of the amygdala activation was observed to be
highly signicant despite the fact that we did not control for menstrual
status, which suggests that hormonal changes play no or only a minor
role with regard to our ndings. Thus, the present results offer
important insights into the effects of cognitive emotion regulation on
5-HTTLPR-mediated amygdala function, while their limited generalizability warrants future studies that control for menstrual cycle as
well as a replication within males.
In conclusion, the results of the present study lend new insights
into our understanding of the complex interplay between willful
950
Acknowledgments
This study was supported by the Volkswagen Foundation (grants
II/80777, II/80774) and the German Federal Ministry of Education
and Research (BMBF; grant 01GS08159) in the context of the National
Genome Research Network (NGFN plus). We thank Christine Schml
for her help in proofreading the manuscript.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.neuroimage.2009.11.078.
References
Amin, Z., Epperson, C.N., Constable, R.T., Canli, T., 2006. Effects of estrogen variation on
neural correlates of emotional response inhibition. Neuroimage 32, 457464.
Ansorge, M.S., Zhou, M., Lira, A., Hen, R., Gingrich, J.A., 2004. Early-life blockade
of the 5-HT transporter alters emotional behavior in adult mice. Science 306,
879881.
Banks, S.J., Eddy, K.T., Angstadt, M., Nathan, P.J., Phan, K.L., 2007. Amygdala-frontal
connectivity during emotion regulation. Soc. Cogn. Affect Neurosci. 2, 303312.
Barr, C.S., Newman, T.K., Schwandt, M., Shannon, C., Dvoskin, R.L., Lindell, S.G.,
Taubman, J., Thompson, B., Champoux, M., Lesch, K.P., Goldman, D., Suomi, S.J.,
Higley, J.D., 2004. Sexual dichotomy of an interaction between early adversity and
the serotonin transporter gene promoter variant in rhesus macaques. Proc. Natl.
Acad. Sci. U. S. A. 101, 1235812363.
Beauregard, M., Levesque, J., Bourgouin, P., 2001. Neural correlates of conscious selfregulation of emotion. J. Neurosci. 21, RC165.
Bechara, A., 2005. Decision making, impulse control and loss of willpower to resist
drugs: a neurocognitive perspective. Nat. Neurosci. 8, 14581463.
Bertolino, A., Arciero, G., Rubino, V., Latorre, V., De Candia, M., Mazzola, V., Blasi, G.,
Caforio, G., Hariri, A., Kolachana, B., Nardini, M., Weinberger, D.R., Scarabino, T., 2005.
Variation of human amygdala response during threatening stimuli as a function of
5HTTLPR genotype and personality style. Biol. Psychiatry 57, 15171525.
Calder, A.J., Lawrence, A.D., Young, A.W., 2001. Neuropsychology of fear and loathing.
Nat. Rev. Neurosci. 2, 352363.
Canli, T., Lesch, K.P., 2007. Long story short: the serotonin transporter in emotion
regulation and social cognition. Nat. Neurosci 10, 11031109.
Canli, T., Omura, K., Haas, B.W., Fallgatter, A., Constable, R.T., Lesch, K.P., 2005.
Beyond affect: a role for genetic variation of the serotonin transporter in neural
activation during a cognitive attention task. Proc. Natl. Acad. Sci. U. S. A. 102,
1222412229.
Caspi, A., Sugden, K., Moftt, T.E., Taylor, A., Craig, I.W., Harrington, H., McClay, J., Mill, J.,
Martin, J., Braithwaite, A., Poulton, R., 2003. Inuence of life stress on depression:
moderation by a polymorphism in the 5-HTT gene. Science 301, 386389.
Chau, W., McIntosh, A.R., 2005. The Talairach coordinate of a point in the MNI space:
how to interpret it. Neuroimage 25, 408416.
Cloninger, C.R., Svrakic, D.M., Przybeck, T.R., 1993. A psychobiological model of
temperament and character. Arch. Gen. Psychiatry 50, 975990.
Costa, P.T., McCrae, R.R., 1992. Revised NEO Personality Inventory (NEO-PI-R) and NEO
Five-Factor Inventory (NEO-FFI)Professional Manual. PAR, Odessa, FL.
Drabant, E.M., McRae, K., Manuck, S.B., Hariri, A.R., Gross, J.J., 2009. Individual
differences in typical reappraisal use predict amygdala and prefrontal responses.
Biol. Psychiatry 65, 367373.
Eippert, F., Bingel, U., Schoell, E.D., Yacubian, J., Klinger, R., Lorenz, J., Buchel, C., 2009.
Activation of the opioidergic descending pain control system underlies placebo
analgesia. Neuron 63, 533543.
Esaki, T., Cook, M., Shimoji, K., Murphy, D.L., Sokoloff, L., Holmes, A., 2005. Developmental
disruption of serotonin transporter function impairs cerebral responses to whisker
stimulation in mice. Proc. Natl. Acad. Sci. U. S. A. 102, 55825587.
Esslinger, C., Walter, H., Kirsch, P., Erk, S., Schnell, K., Arnold, C., Haddad, L., Mier, D.,
Opitz von Boberfeld, C., Raab, K., Witt, S.H., Rietschel, M., Cichon, S., MeyerLindenberg, A., 2009. Neural mechanisms of a genome-wide supported psychosis
variant. Science 324, 605.
Friston, K.J., Buechel, C., Fink, G.R., Morris, J., Rolls, E., Dolan, R.J., 1997. Psychophysiological and modulatory interactions in neuroimaging. Neuroimage 6, 218229.
Gaspar, P., Cases, O., Maroteaux, L., 2003. The developmental role of serotonin: news
from mouse molecular genetics. Nat. Rev. Neurosci. 4, 10021012.
Gater, R., Tansella, M., Korten, A., Tiemens, B.G., Mavreas, V.G., Olatawura, M.O., 1998.
Sex differences in the prevalence and detection of depressive and anxiety disorders
in general health care settings: report from the World Health Organization
Collaborative Study on Psychological Problems in General Health Care. Arch. Gen.
Psychiatry 55, 405413.
Goldin, P.R., McRae, K., Ramel, W., Gross, J.J., 2008. The neural bases of emotion
regulation: reappraisal and suppression of negative emotion. Biol. Psychiatry 63,
577586.
Goldstein, J.M., Jerram, M., Poldrack, R., Ahern, T., Kennedy, D.N., Seidman, L.J., Makris,
N., 2005. Hormonal cycle modulates arousal circuitry in women using functional
magnetic resonance imaging. J. Neurosci. 25, 93099316.
Green, A.E., Munafo, M.R., Deyoung, C.G., Fossella, J.A., Fan, J., Gray, J.R., 2008. Using
genetic data in cognitive neuroscience: from growing pains to genuine insights.
Nat. Rev. Neurosci. 9, 710720.
Gross, J.J., 1999. Emotion regulation: past, present, future. Cogn. Emot. 13, 551573.
Gross, J.J., John, O.P., 2003. Individual differences in two emotion regulation processes:
implications for affect, relationships, and well-being. J. Pers. Soc. Psychol. 85,
348362.
Haggard, P., 2008. Human volition: towards a neuroscience of will. Nat. Rev. Neurosci. 9,
934946.
Hahn, M.K., Blakely, R.D., 2007. The functional impact of SLC6 transporter genetic
variation. Annu. Rev. Pharmacol. Toxicol. 47, 401441.
Hariri, A.R., Holmes, A., 2006. Genetics of emotional regulation: the role of the serotonin
transporter in neural function. Trends Cogn. Sci. 10, 182191.
Hariri, A.R., Mattay, V.S., Tessitore, A., Kolachana, B., Fera, F., Goldman, D., Egan, M.F.,
Weinberger, D.R., 2002. Serotonin transporter genetic variation and the response of
the human amygdala. Science 297, 400403.
Hariri, A.R., Mattay, V.S., Tessitore, A., Fera, F., Weinberger, D.R., 2003. Neocortical
modulation of the amygdala response to fearful stimuli. Biol. Psychiatry 53, 494501.
Hariri, A.R., Drabant, E.M., Munoz, K.E., Kolachana, B.S., Mattay, V.S., Egan, M.F.,
Weinberger, D.R., 2005. A susceptibility gene for affective disorders and the
response of the human amygdala. Arch. Gen. Psychiatry 62, 146152.
Hariri, A.R., Drabant, E.M., Weinberger, D.R., 2006. Imaging genetics: perspectives from
studies of genetically driven variation in serotonin function and corticolimbic
affective processing. Biol. Psychiatry 59, 888897.
Heinz, A., Braus, D.F., Smolka, M.N., Wrase, J., Puls, I., Hermann, D., Klein, S., Grusser,
S.M., Flor, H., Schumann, G., Mann, K., Buchel, C., 2005. Amygdala-prefrontal
coupling depends on a genetic variation of the serotonin transporter. Nat. Neurosci.
8, 2021.
Hensler, J.G., 2006. Serotonergic modulation of the limbic system. Neurosci. Biobehav.
Rev. 30, 203214.
Hoefgen, B., Schulze, T.G., Ohlraun, S., von Widdern, O., Hofels, S., Gross, M., Heidmann,
V., Kovalenko, S., Eckermann, A., Kolsch, H., Metten, M., Zobel, A., Becker, T., Nothen,
M.M., Propping, P., Heun, R., Maier, W., Rietschel, M., 2005. The power of sample
size and homogenous sampling: association between the 5-HTTLPR serotonin
transporter polymorphism and major depressive disorder. Biol. Psychiatry 57,
247251.
Johnstone, T., van Reekum, C.M., Urry, H.L., Kalin, N.H., Davidson, R.J., 2007. Failure to
regulate: counterproductive recruitment of topdown prefrontalsubcortical
circuitry in major depression. J. Neurosci. 27, 88778884.
Kessler, R.C., McGonagle, K.A., Swartz, M., Blazer, D.G., Nelson, C.B., 1993. Sex and
depression in the National Comorbidity Survey. I: lifetime prevalence, chronicity
and recurrence. J. Affect. Disord. 29, 8596.
Lang, P.J., Bradley, M.M., Cuthbert, B.N., 2008. International Affective Picture System
(IAPS): affective ratings of pictures and instruction manual. Technical Report A-8.
University of Florida, Gainesville, FL.
Lau, J.Y., Goldman, D., Buzas, B., Fromm, S.J., Guyer, A.E., Hodgkinson, C., Monk, C.S.,
Nelson, E.E., Shen, P.H., Pine, D.S., Ernst, M., 2009. Amygdala function and 5-HTT
gene variants in adolescent anxiety and major depressive disorder. Biol. Psychiatry
65, 349355.
Lesch, K.P., Bengel, D., Heils, A., Sabol, S.Z., Greenberg, B.D., Petri, S., Benjamin, J., Muller,
C.R., Hamer, D.H., Murphy, D.L., 1996. Association of anxiety-related traits with a
polymorphism in the serotonin transporter gene regulatory region. Science 274,
15271531.
Levesque, J., Joanette, Y., Mensour, B., Beaudoin, G., Leroux, J.M., Bourgouin, P.,
Beauregard, M., 2004. Neural basis of emotional self-regulation in childhood.
Neuroscience 129, 361369.
Little, K.Y., McLaughlin, D.P., Zhang, L., Livermore, C.S., Dalack, G.W., McFinton, P.R.,
DelProposto, Z.S., Hill, E., Cassin, B.J., Watson, S.J., Cook, E.H., 1998. Cocaine, ethanol,
and genotype effects on human midbrain serotonin transporter binding sites and
mRNA levels. Am. J. Psychiatry 155, 207213.
MacDonald, K.B., 2008. Effortful control, explicit processing, and the regulation of
human evolved predispositions. Psychol. Rev. 115, 10121031.
Maciejewski, P.K., Prigerson, H.G., Mazure, C.M., 2001. Sex differences in event-related
risk for major depression. Psychol. Med. 31, 593604.
Maren, S., Quirk, G.J., 2004. Neuronal signalling of fear memory. Nat. Rev. Neurosci. 5,
844852.
McRae, K., Ochsner, K.N., Mauss, I.B., Gabrieli, J.J.D., Gross, J.J., 2008. Gender differences
951
Satpute, A.B., Lieberman, M.D., 2006. Integrating automatic and controlled processes
into neurocognitive models of social cognition. Brain Res. 1079, 8697.
Schaefer, S.M., Jackson, D.C., Davidson, R.J., Aguirre, G.K., Kimberg, D.Y., ThompsonSchill, S.L., 2002. Modulation of amygdalar activity by the conscious regulation of
negative emotion. J. Cogn. Neurosci. 14, 913921.
Schienle, A., Schafer, A., Stark, R., Walter, B., Vaitl, D., 2005. Neural responses of OCD
patients towards disorder-relevant, generally disgust-inducing and fear-inducing
pictures. Int. J. Psychophysiol. 57, 6977.
Shioe, K., Ichimiya, T., Suhara, T., Takano, A., Sudo, Y., Yasuno, F., Hirano, M., Shinohara,
M., Kagami, M., Okubo, Y., Nankai, M., Kanba, S., 2003. No association between
genotype of the promoter region of serotonin transporter gene and serotonin
transporter binding in human brain measured by PET. Synapse 48, 184188.
Smolka, M.N., Buhler, M., Schumann, G., Klein, S., Hu, X.Z., Moayer, M., Zimmer, A.,
Wrase, J., Flor, H., Mann, K., Braus, D.F., Goldman, D., Heinz, A., 2007. Genegene
effects on central processing of aversive stimuli. Mol. Psychiatry 12, 307317.
Soon, C.S., Brass, M., Heinze, H.J., Haynes, J.D., 2008. Unconscious determinants of free
decisions in the human brain. Nat. Neurosci. 11, 543545.
Staley, J.K., Sanacora, G., Tamagnan, G., Maciejewski, P.K., Malison, R.T., Berman, R.M.,
Vythilingam, M., Kugaya, A., Baldwin, R.M., Seibyl, J.P., Charney, D., Innis, R.B., 2006.
Sex differences in diencephalon serotonin transporter availability in major
depression. Biol. Psychiatry 59, 4047.
Staudinger, M.R., Erk, S., Abler, B., Walter, H., 2009. Cognitive reappraisal modulates
expected value and prediction error encoding in the ventral striatum. Neuroimage
47, 713721.
Stefanacci, L., Suzuki, W.A., Amaral, D.G., 1996. Organization of connections between
the amygdaloid complex and the perirhinal and parahippocampal cortices in
macaque monkeys. J. Comp. Neurol. 375, 552582.
Stein, J.L., Wiedholz, L.M., Bassett, D.S., Weinberger, D.R., Zink, C.F., Mattay, V.S., MeyerLindenberg, A., 2007. A validated network of effective amygdala connectivity.
Neuroimage 36, 736745.
Talairach, J., Tournoux, P., 1988. Co-planar Stereotaxic Atlas of the Human Brain. Georg
Thieme Verlag, Stuttgart, Germany.
van Dyck, C.H., Malison, R.T., Staley, J.K., Jacobsen, L.K., Seibyl, J.P., Laruelle, M., Baldwin,
R.M., Innis, R.B., Gelernter, J., 2004. Central serotonin transporter availability
measured with [123I]{beta}-CIT SPECT in relation to serotonin transporter
genotype. Am. J. Psychiatry 161, 525531.
Wager, T.D., Davidson, M.L., Hughes, B.L., Lindquist, M.A., Ochsner, K.N., 2008.
Prefrontalsubcortical pathways mediating successful emotion regulation. Neuron
59, 10371050.
Walderhaug, E., Magnusson, A., Neumeister, A., Lappalainen, J., Lunde, H., Refsum, H.,
Landro, N.I., 2007. Interactive effects of sex and 5-HTTLPR on mood and impulsivity
during tryptophan depletion in healthy people. Biol. Psychiatry 62, 593599.
Walter, H., 2001. The Neurophilosophy of Will. MTI Press, Boston.
Walter, H., von Kalckreuth, A., Schardt, D., Stephan, A., Goschke, T., Erk, S., 2009. The
temporal dynamics of voluntary emotion regulation. PLoS ONE e6726, 4.
Wegner, D., 2004. The Illusion of Conscious Will. MIT, Cambridge, MA.
Weiskopf, N., Hutton, C., Josephs, O., Deichmann, R., 2006. Optimal EPI parameters for
reduction of susceptibility-induced BOLD sensitivity losses: a whole-brain analysis
at 3 T and 1.5 T. Neuroimage 33, 493504.
Wendland, J.R., Martin, B.J., Kruse, M.R., Lesch, K.P., Murphy, D.L., 2006. Simultaneous
genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR
and rs25531. Mol. Psychiatry 11, 224226.
Wilhelm, K., Parker, G., Hadzi-Pavlovic, D., 1997. Fifteen years on: evolving ideas in
researching sex differences in depression. Psychol. Med. 27, 875883.